glp-1 and kidney disease Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes GLP1 Receptor Agonists vs SGLT2-I
Description
The UK has approved a once daily Wegovy semaglutide pill for weight loss, marking Europes first oral GLP-1 treatment
Calocurb GLP-1 Activator
Important update for our community The White House recently announced that TrumpRX will be lowering the cost of brand-name Ozempic and Wegovy to $350/month
This systematic review and meta-analysis aims to update the evidence on the impact of GLP-1 RAs on EGD outcomes, evaluate the effect of concurrent colonoscopy (CLN) on GRC, and assess the influence of different GLP-1 RA agents on GRC
